Despite COVID-19, bioscience economy remains resilient

According to the recently published report by the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA), “Driving the Bioscience Economy Forward During the COVID-19 Pandemic,” state and regional initiatives ensured that the United States continues to be competitive in the global marketplace as a leader in the bioscience industry—pandemic or not.

We spoke to Pete Pellerito, Senior Policy Adviser for Federal/State Economic Development & Technology Transfer Lead at BIO, about the report and how states are driving America’s bioscience economy forward.

Click here to read the exclusive story on BIO.org.

Scroll to Top
SUBSCRIBE TO THE FREE GOOD DAY BIO NEWSLETTER